Diabetic Macular Edema (DME) Market Is Expected To Offer Substantial Growth Opportunities, Reaching $6 Billion By 2030

 


What Is The Expected Valuation Of The Diabetic Macular Edema (DME) Market In The Upcoming Years, And How Quickly Is It Set To Grow?
 The diabetic macular edema (dme) market size has grown steadily in recent years. It will grow from $4.88 billion in 2025 to $5.09 billion in 2026 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to rising prevalence of diabetic eye disease, limited early detection practices, increasing vision impairment cases, reliance on hospital-based ophthalmology care, growth in diabetes duration.
 
 The diabetic macular edema (dme) market size is expected to see steady growth in the next few years. It will grow to $6 billion in 2030 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to advancements in biologic therapies, expansion of ai-driven eye screening, growth of specialty eye clinics, increasing awareness of diabetic eye complications, aging diabetic population. Major trends in the forecast period include increasing adoption of anti-vegf therapies, rising use of advanced retinal imaging technologies, expansion of early diagnosis and monitoring programs, growing focus on vision preservation treatments, integration of AI-based ophthalmic screening.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=21169&type=smp
 
 Which Major Drivers Are Accelerating Expansion Within The Diabetic Macular Edema (DME) Market?
 The increase in prevalence of diabetes is expected to drive the growth of the diabetic macular edema (DME) market going forward. The increasing prevalence of diabetes is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition. Diabetes causes diabetic macular edema by damaging retinal blood vessels, leading to leakage of fluid into the macula and resulting in swelling. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increase in prevalence of diabetes is driving the growth of the diabetic macular edema (DME) market.
 
 Which Segments Are Expected To Shape The Future Direction Of The Diabetic Macular Edema (DME) Market?
 The diabetic macular edema (dme) market covered in this report is segmented — 
 
 1) By Treatment: Anti-VEGF Therapy, Corticosteroids, Laser Therapy, Surgical Intervention 
 2) By Disease Stage: Early Stage, Moderate Stage, Advanced Stage 
 3) By Patient Demographics: Adults, Elderly, Children
 4) By Route Of Administration: Intravitreal Injection, Topical, Systemic
 5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
 
 Subsegments:
 1) By Anti-VEGF Therapy: Monoclonal Antibodies, Recombinant Protein-Based Therapies 
 2) By Corticosteroids: Intravitreal Steroid Injections, Injectable Sustained-Release Corticosteroids 
 3) By Laser Therapy: Focal Laser Photocoagulation, Panretinal Photocoagulation 
 4) By Surgical Intervention: Vitrectomy, Membrane Peeling
 
 Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Diabetic Macular Edema (DME) Market?
 Major companies operating in the diabetic macular edema (DME) market are focusing on incorporating sustained-delivery implant technology such as refillable ocular implants to enhance treatment durability, patient compliance, and vision-maintenance efficiency. Refillable ocular implants are devices surgically placed in the eye that continuously release medication over extended periods, enabling capabilities such as less frequent dosing, sustained therapeutic exposure, and reduced treatment burden. For instance, in February 2025, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology and pharmaceutical company, received approval for Susvimo (ranibizumab 100 mg/mL delivered via the port delivery platform), a refillable ocular implant designed to treat DME, featuring continuous delivery of ranibizumab, refill intervals as infrequent as twice per year, and non-inferior vision outcomes compared with monthly intravitreal injections. Susvimo improves patient adherence, reduces injection burden, and supports sustained vision preservation. 
 
 Who Are The Companies Setting The Competitive Benchmark In The Diabetic Macular Edema (DME) Market?
 Major companies operating in the diabetic macular edema (dme) market are Roche Holding AG, Bayer AG, Novartis AG, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Carl Zeiss AG, Topcon Corporation, Optos plc, Allergan plc, Chengdu Kanghong Pharmaceutical Group, Kodiak Sciences, Opthea Limited, Oxurion NV, Aerie Pharmaceuticals Inc, Coherus BioSciences, KalVista Pharmaceuticals Inc, Araim Pharmaceuticals Inc, Acucela Inc, Antisense Therapeutics Limited, BCN Peptides SA, Ampio Pharmaceuticals Inc, Oculis SA, ThromboGenics NV, EyePoint Pharmaceuticals Inc. 
 
 Get Your In-Depth Diabetic Macular Edema (DME) Market Report Now:
 https://www.thebusinessresearchcompany.com/report/diabetic-macular-edema-dme-global-market-report
 
 Which Region Currently Accounts For The Largest Share Of The Diabetic Macular Edema (DME) Market?
 North America was the largest region in the diabetic macular edema (DME) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (dme) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Gear Box And Gear Motor Market 2024-2033: Technological Advancements, Competitive Landscape and Strategies

Image
  The gear box and gear motor global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market. Gear Box And Gear Motor Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities. Market Size - The gear box and gear motor market size has grown strongly in recent years. It will grow from $16.3 billion in 2023 to $17.22 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rapid growth in heavy machinery, early adoption in aviation and aerospace, pioneering industry applications, world ...
Read more

Automotive Overhead Console Market Size Forecasted to Reach $51.52 Billion by 2029 with 5.4% CAGR

Image
  The Business Research Company's report on the Automotive Overhead Console Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities. #What are the primary drivers fueling the growth of the automotive overhead console market in recent years?# The increasing demand for passenger vehicles internationally is expected to propel the growth of the automotive overhead console market going forward. A passenger vehicle is a multi-track automobile with at least two axles, its driver is automatically propelled and commonly has four or more wheels. Automotive overhead consoles are utilized to conceal small objects for quick access in passenger automobiles. It is attached to the roof to help with navigation. For instance, in January 2023, according to a report shared by The European Automobile Manufacturers Association, a Belgium-based main lobbying and standards group for the...
Read more

Natural Insect Repellents Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

Image
  Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the natural insect repellents industry.    Natural Insect Repellents Market Analysis & Forecast: 2025–2029  The natural insect repellents market size has grown strongly in recent years. It will grow from $1.9 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising government initiatives for vector-borne disease prevention, environmental protection policies supporting eco-friendly products, growing consumer preference for toxin-free products, increasing demand for child-safe and pet-safe repellents, growing popularity of sustainable and biodegradable products.    The natural insect repellents market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. Th...
Read more